Introducing CODE3
Drawing on 12 years of rigorous research and clinical refinement, our patent-pending formula (63/800,093) harnesses Tranexamic Acid, Bakuchiol, and Quercetin to even skin tone, diminish visible signs of aging, and accelerate post-procedure recovery.
CODE3 Partnership Program
CODE3 is available through our Partnership Program at select plastic surgery practices. See our list of providers offering premium skin care.
Participating Providers
-
Dr. Melinda Costa
2516 Samaritan Dr Suite N, San Jose, CA 95124
Partnership Benefits
Cutting-edge formula
Co-marketed product
Win-win practice economics
Key Ingredients
Tranexamic Acid
Clinically shown to inhibit melanin pathways, reduce dark spots and even skin tone.
Bakuchiol
A plant-based retinol alternative that stimulates collagen production and smooths fine lines without the irritation of retinoids.
Quercetin
Potent antioxidant that calms inflammation and protects skin from environmental stressors.
The Science: TXA for Post-Procedure-Recovery
TXA: Rosacea Inflammation Reduction
A randomized, vehicle controlled, split-face study was performed on 30 rosacea patients. This study involved 2 weeks of 3% tranexamic acid solution treatment and vehicle control treatment. Individuals with rosacea expressed a higher baseline level of PAR-2 compared with normal skin. Tranexamic acid improved the permeability barrier function in rosacea patients.
Learn MoreTXA: Post Microneedling Study
A split-face randomized trial (n=40) found that microneedling plus 10% topical tranexamic acid produced substantially greater melasma improvement by 8 weeks than microneedling plus control (about 66% vs 21% improvement in mMASI).
Learn MoreTranexamic Acid: Reduce Post-Surgical Procedure Bruising
A 54-patient randomized, double-blind, placebo-controlled trial evaluated topical 3% TXA applied intraoperatively during facial/scalp reconstruction after skin-cancer excision. The TXA group had lower measured blood loss (11.4 mL vs 17.6 mL) and far less post-procedure bruising/ecchymosis (3.8% vs 82.1%).
Learn MoreThe Science: Skin Evening & Anti-Aging
Topical Tranexamic Acid as a Promising Treatment for Melasma
Demonstrated that 3% topical TA safely and effectively reduces hyperpigmentation in melasma patients, with significant MASI score improvements over 12 weeks.
Read Full Paper5% Tranexamic Acid vs. 3% Hydroquinone in Melasma: A Randomized Trial
This RCT compared 5% TA solution with 3% hydroquinone cream in Indian skin, showing equivalent MASI reduction but higher patient satisfaction and fewer adverse effects with TA.
Read Full PaperTXA in Melasma Management: Systematic Review & Meta-Analysis
A comprehensive meta-analysis of RCTs confirming that topical and oral TXA significantly improve melasma outcomes with a favorable safety profile.
Read Full PaperTXA for Anti-Aging Benefits
An injectable gel made of hyaluronic acid, niacinamide, and tranexamic acid that, in a study of 49 women, noticeably improved skin hydration, firmness, smoothness, and evenness over 70 days.
Read Full PaperTestimonials
*Everybody responds a little bit differently to topical products. If you're one of those individuals who notices irritation, we recommend to reduce or stop use.